Navigation between EQA and sustainability

Articles in the same Issue

1. Frontmatter
2. Editorials
3. Multi-cancer early detection: searching for evidence
4. High sensitivity cardiac troponin assays, rapid myocardial infarction rule-out algorithms, and assay performance
5. Reviews
6. Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine
7. Copeptin as a diagnostic and prognostic biomarker in pediatric diseases
8. Opinion Papers
9. The Unholy Grail of cancer screening: or is it just about the Benjamins?
10. Critical appraisal of the CLSI guideline EP09c “measurement procedure comparison and bias estimation using patient samples”
11. Tumor markers determination in malignant pleural effusion: pearls and pitfalls
12. Contribution of laboratory medicine and emerging technologies to cardiovascular risk reduction via exposome analysis: an opinion of the IFCC Division on Emerging Technologies
13. Guidelines and Recommendations
14. Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
15. Genetics and Molecular Diagnostics
16. Expanded carrier screening for 224 monogenic disease genes in 1,499 Chinese couples: a single-center study
17. General Clinical Chemistry and Laboratory Medicine
18. How do experts determine where to intervene on test ordering? An interview study
19. New concept for control material in glucose point-of-care-testing for external quality assessment schemes
20. Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs
21. Analytical evaluation of eight qualitative FIT for haemoglobin products, for professional use in the UK
22. Colorimetric correcting for sample concentration in stool samples
23. Reference Values and Biological Variations
24. Assessment of canonical diurnal variations in plasma glucose using quantile regression modelling and Chronomaps
25. Inconsistency in ferritin reference intervals across laboratories: a major concern for clinical decision making
26. Establishing the TSH reference intervals for healthy adults aged over 70 years: the Australian ASPREE cohort study
27. Hematology and Coagulation
28. The EuroFlow PIDOT external quality assurance scheme: enhancing laboratory performance evaluation in immunophenotyping of rare lymphoid immunodeficiencies
29. Clinical value of smear review of flagged samples analyzed with the Sysmex XN hematology analyzer
30. Cardiovascular Diseases
31. Evidence for stability of cardiac troponin T concentrations measured with a high sensitivity TnT test in serum and lithium heparin plasma after six-year storage at −80 °C and multiple freeze-thaw cycles
32. Letters to the Editor
33. Impact of high-sensitivity cardiac troponin I assay imprecision on the safety of a single-sample rule-out approach for myocardial infarction
34. Why is single sample rule out of non-ST elevation myocardial infarction using high-sensitivity cardiac troponin T safe when analytical imprecision is so high? A joint statistical and clinical demonstration
35. Iron deficiency and iron deficiency anemia in transgender populations: what’s different?
36. The information about the metrological traceability pedigree of the in vitro diagnostic calibrators should be improved: the case of plasma ethanol
37. Time to refresh and integrate the JCTLM database entries for total bilirubin: the way forward
38. Navigation between EQA and sustainability
39. C-terminal alpha-1-antitrypsin peptides as novel predictor of hospital mortality in critically ill COVID-19 patients
40. Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
41. A simple gatekeeping intervention improves the appropriateness of blood urea nitrogen testing
42. Congress Abstracts
43. 16ª Reunião Científica da Sociedade Portuguesa de Medicina Laboratorial - SPML